4//SEC Filing
Vazquez Chris 4
Accession 0000905148-25-003933
CIK 0001439725other
Filed
Nov 12, 7:00 PM ET
Accepted
Nov 13, 4:54 PM ET
Size
8.5 KB
Accession
0000905148-25-003933
Insider Transaction Report
Form 4
BIODESIX INCBDSX
Vazquez Chris
Chief Accounting Officer
Transactions
- Sale
Common Stock
2025-11-10$7.62/sh−13$99→ 936 total - Exercise/Conversion
Common Stock
2025-11-10+31→ 949 total - Exercise/Conversion
Restricted Stock Units
2025-11-10−31→ 29 total→ Common Stock (31 underlying)
Footnotes (4)
- [F1]These numbers have been adjusted to reflect the one-for-twenty reverse stock split effective September 15, 2025.
- [F2]Each restricted stock unit (the "RSU") represents a contingent right to receive one share of the Issuer's Common Stock.
- [F3]These shares of the Issuer's Common Stock were sold automatically to cover taxes upon the vesting of RSUs.
- [F4]These RSUs vest in a series of sixteen successive quarterly installments measured from February 8, 2022, generally subject to the Reporting Person's continued service with the Issuer, and have no expiration date.
Documents
Issuer
BIODESIX INC
CIK 0001439725
Entity typeother
Related Parties
1- filerCIK 0001980594
Filing Metadata
- Form type
- 4
- Filed
- Nov 12, 7:00 PM ET
- Accepted
- Nov 13, 4:54 PM ET
- Size
- 8.5 KB